
CAS 939681-36-4
:tert-Butyl 3,5-bis(2-fluorobenzylidene)-4-oxopiperidine-1-carboxylate
Description:
Tert-Butyl 3,5-bis(2-fluorobenzylidene)-4-oxopiperidine-1-carboxylate is a synthetic organic compound characterized by its complex structure, which includes a piperidine ring, multiple aromatic fluorobenzylidene groups, and a tert-butyl ester functional group. This compound typically exhibits properties associated with both piperidine derivatives and fluorinated aromatic compounds, such as increased lipophilicity and potential biological activity. The presence of the fluorine atoms can enhance the compound's metabolic stability and influence its interaction with biological targets. Its ester functionality suggests it may undergo hydrolysis under certain conditions, releasing the corresponding carboxylic acid. Additionally, the compound may exhibit interesting optical properties due to the presence of the conjugated double bonds in the benzylidene moieties. Overall, this compound may be of interest in medicinal chemistry for its potential applications in drug development, particularly in the design of novel therapeutic agents. However, specific biological activity and reactivity would require further investigation through experimental studies.
Formula:C22H19F2NO3
Synonyms:- tert-Butyl 3,5-bis(2-fluorobenzylidene)-4-oxopiperidine-1-carboxylate
- G5-7
- 1-Piperidinecarboxylic acid, 3,5-bis[(2-fluorophenyl)methylene]-4-oxo-, ethyl ester
- antiangiogenic,inhibit,Apoptosis,JAK,Glioma,G-5-7,cycle,G5 7,phase,G57,STAT3,cell,Inhibitor,EGFR,Janus kinase,G5-7,mTOR
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
G5-7
CAS:G5-7 is an oral JAK2 inhibitor targeting EGFR/STAT3 phosphorylation with potential for glioma research.Formula:C22H19F2NO3Purity:97.3%Color and Shape:SolidMolecular weight:383.39

